Type 2 diabetes sufferers are being urged to watch for a killer genital infection that rots your privates.
Experts are warning that one of the newer drugs being prescribed to treat the condition, which affects more than 2.7 million in the UK, could have a dangerous side-effect.
New research has found a link between SGLT2 inhibitors and Fournier gangrene – a flesh-eating bacteria that affects soft tissue in the genitals.
The potentially life-threatening infection is more common in men as it targets the scrotum or penis, where there are plenty of small crevices that trap bacteria.
It can also develop in the perineum – the area between the anus and vulva or scrotum – and around the anus, meaning women are also at risk.
SGLT2 inhibitors are used to help people with type 2 diabetes improve their glycemic control by preventing the kidney from reabsorbing glucose.
In the UK they are better known as Forxiga (Dapagliflozin), Invokana (Canagliflozin), and Jardiance (Empagliflozin).